
Journal of Alzheimer s Disease Reports, Год журнала: 2025, Номер 9
Опубликована: Янв. 1, 2025
Neuroinflammation plays a crucial role in the progression of Alzheimer's disease (AD), contributing to both cognitive decline and motor impairment. This review examines dual impact neuroinflammatory processes, particularly activation microglia astrocytes, dysregulated release pro-inflammatory cytokines chemokines, on cognition balance AD. leads synaptic dysfunction, oxidative stress, mitochondrial impairment, which accelerate neuronal damage disrupt circuits, such as those cortex, basal ganglia, cerebellum. These disruptions result symptoms like gait disruption issues, reflecting close interplay between functions. In addition, we highlighted blood-brain barrier peripheral neuropathy increasing dysfunction. Despite promise anti-inflammatory treatments, clinical trials with non-steroidal drugs have yielded mixed results, underscoring need for early intervention more targeted therapies. Therefore, understanding mechanisms linking neuroinflammation impairments may guide development new therapeutic approaches aimed at mitigating complex pathology
Язык: Английский